Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELL | P14151 | 1/20 | 0.70 |
| ▸ | SELP | P16109 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.65 |
| ▸ | CA1 | P00915 | 4/20 | 0.65 |
| ▸ | CA2 | P00918 | 4/20 | 0.65 |
| ▸ | HPGD | P15428 | 3/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | CA12 | O43570 | 3/20 | 0.65 |
| ▸ | CA7 | P43166 | 3/20 | 0.65 |
| ▸ | CA9 | Q16790 | 3/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.65 |
| ▸ | CA6 | P23280 | 2/20 | 0.65 |
| ▸ | HMGB1 | P09429 | 2/20 | 0.65 |
| ▸ | CA4 | P22748 | 1/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.61 |
| ▸ | MMP2 | P08253 | 2/20 | 0.61 |
| ▸ | ALB | P02768 | 1/20 | 0.61 |
| ▸ | G6PD | P11413 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,3-Dihydroxybenzoic Acid SCHEMBL21114367 | 1.00 | SELL (0.70) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL37458 | 1.00 | SELL (0.70) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL10772312 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL2831362 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL31280701 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL23062831 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL2033962 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL19953771 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL3980950 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 | |
| 2,3-Dihydroxybenzoic Acid SCHEMBL11026760 | 0.98 | SELL (0.67) | SELLSELPALDH1A1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3953941-B1 | SYSTEM AND METHOD FOR BIOREMEDIATION OF POLLUTANTS | TATA CONSULTANVY SERVICES (IN) | 2025-07-02 | — | — | EP | claimed |
| CN-116981816-A | Composition for preventing or reducing splash during use of a toilet | 洛伦·阿佐里 | 2023-10-31 | — | — | CN | claimed |
| CN-113975458-B | Nano-silver/double-modified chitosan antibacterial hydrogel dressing for indicating wound infection condition through color-changing effect and preparation method thereof | 浙江大学 | 2022-07-26 | — | — | CN | claimed |
| US-20250179544-A1 | PRODUCTION OF CORYNANTHE-TYPE MONOTERPENE INDOLE ALKALOID COMPOUNDS IN A HETEROLOGOUS HOST | CB Therapeutics (US) | 2025-06-05 | — | — | US | disclosed |
| CN-111511896-B | Scaffold material for stem cell culture and stem cell culture method using same | 积水化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-111511895-B | Scaffold material for stem cell culture and stem cell culture method using same | 积水化学工业株式会社 | 2025-05-13 | — | — | CN | disclosed |
| CN-119968276-A | On-press development type lithographic printing plate precursor, method for producing lithographic printing plate, and lithographic printing method | 富士胶片株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-119948587-A | Solid electrolytic capacitor and method of manufacturing the same | 日本贵弥功株式会社 | 2025-05-06 | — | — | CN | disclosed |
| CN-119923703-A | Solid electrolytic capacitor and method of manufacturing the same | 日本贵弥功株式会社 | 2025-05-02 | — | — | CN | disclosed |
| CN-119866531-A | Solid electrolytic capacitor | 日本贵弥功株式会社 | 2025-04-22 | — | — | CN | disclosed |
| EP-4532596-A1 | CURABLE FLUOROPOLYMER COMPOSITIONS COMPRISING AN AMMONIUM HYDROXYBENZOATE CATALYST AND A BIS PHTHALONITRILE-CONTAINING COMPOUND AND CURED ARTICLES THEREFROM | 3M Innovative Properties Company (US) | 2025-04-09 | — | — | EP | disclosed |
| WO-2022229751-A1 | CURABLE FLUOROELASTOMER COMPOSITIONS CONTAINING AMMONIUM HYDROXYBENZOATE CATALYSTS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2022-11-03 | — | — | WO | disclosed |
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| CN-115032324-A | Establishment and application of frozen shrimp meat pathogenic bacteria pollution model | 台州学院 | 2022-09-09 | — | — | CN | disclosed |
| CN-114902361-A | Solid electrolytic capacitor | 日本贵弥功株式会社 | 2022-08-12 | — | — | CN | disclosed |
| CN-113975458-B | Nano-silver/double-modified chitosan antibacterial hydrogel dressing for indicating wound infection condition through color-changing effect and preparation method thereof | 浙江大学 | 2022-07-26 | — | — | CN | disclosed |
| CN-113975458-B | Nano-silver/double-modified chitosan antibacterial hydrogel dressing for indicating wound infection condition through color-changing effect and preparation method thereof | 浙江大学 | 2022-07-26 | — | — | CN | disclosed |
| US-20220096349-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | MIYOSHI OIL & FAT CO., LTD. (JP) | 2022-03-31 | — | — | US | disclosed |
| CN-114174491-A | Modified E.coli strains NISSLE and treatment of gastrointestinal disorders | 国家医疗保健研究所 | 2022-03-11 | — | — | CN | disclosed |
| CN-113975458-A | Nano-silver/double-modified chitosan antibacterial hydrogel dressing for indicating wound infection condition through color-changing effect and preparation method thereof | 浙江大学 | 2022-01-28 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220096349-A1 | COSMETIC COMPOUNDING AGENT, COSMETIC AND PRODUCTION METHOD THEREOF | H1-0, H1-4, H1-2 | SELL 4811/4885SELP 4770/4885ALDH1A1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.